---
title: "Age-Dependent Differences in Disease Risk for People with Down Syndrome"
id: "medrxiv-14-effects-of-age-on-the-association-between-down-syndrome-and-common-disease"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-14-effects-of-age-on-the-association-between-down-syndrome-and-common-disease"
content_type: "clinical_feed_article"
specialty: "Pediatrics"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.09.02.26362053v1?rss=1"
published_at: "2026-09-07T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Age-Dependent Differences in Disease Risk for People with Down Syndrome
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-14-effects-of-age-on-the-association-between-down-syndrome-and-common-disease
- **Specialty:** [Pediatrics](https://medichelpline.com/clinical-feed/pediatrics.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.09.02.26362053v1?rss=1)
- **Published At:** 2026-09-07T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This retrospective longitudinal cohort study compared incidence of ten common conditions between 4,912 individuals with **Down syndrome (DS)** and 37,924 typically developing (TD) controls seen in a Midwest healthcare system from 2005–May 2025, totaling 25,896 and 149,078 person-years respectively. - The cohort with DS had a median age of 24 years and was 48% female. Analyses used generalized additive mixed models to estimate incidence rate ratio (IRR) trajectories and Wald tests to evaluate age modification of associations. - The study evaluated acute sinusitis, anxiety, asthma, depression, gastroesophageal reflux disease (GERD), nervous system disorders, respiratory failure, thyroid disorders, vasomotor/allergic rhinitis, and vitamin D deficiency. - Age-related effect modification was detected for 6 of the 10 conditions examined. The study reports specific age-varying patterns for **anxiety**, **depression**, **gastroesophageal disease**, **respiratory failure**, and **vitamin D deficiency**; the sixth condition with modification was not detailed in the abstract. - For **anxiety**, IRR was markedly lower in early childhood for DS versus TD (at age 5 IRR 0.23, 95% CI 0.19–0.29) but risk in DS rose with age and approached parity with TD around age 65. - **Depression** showed a similar age-related increase in relative incidence among individuals with DS compared with TD controls, approaching comparable levels in older age. - **Gastroesophageal disease (GERD)** had a largely null association overall but showed elevated incidence in DS between ages 1–8 (approximately 5–7 cases per 1,000 person-years) versus controls (2–3 per 1,000 PYs). - **Respiratory failure** incidence in DS remained similar to controls until mid-to-late adulthood, then rose sharply between ages ~53–70 (13–30 cases per 1,000 PYs in DS vs 8–9 per 1,000 PYs in TD). - **Vitamin D deficiency** incidence in DS fluctuated with a peak around age 20 (IRR 2.34, 95% CI 2.02–2.72). - Authors conclude these age-modified associations underscore the need for population-specific, age-informed screening and prevention guidelines for people with DS. Data are not publicly available due to protected health information; analytic code available on request.
## Clinical Analysis & Structured Key Points
Effects of Age on the Association between Down Syndrome and Common Disease Conditions | medRxiv Skip to main content Effects of Age on the Association between Down Syndrome and Common Disease Conditions View ORCID Profile Akaninyene Noah , Hannah Tavalire , Veronica Fitzpatrick , Hannah Graham , Shelly Verma , Laura Krohn , Katie Frank , Daniel Vockeroth , Brian Chicoine doi: https://doi.org/10.64898/2026.09.02.26362053 Akaninyene Noah Advocate Health Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Akaninyene Noah For correspondence: akaninyene.noah{at}advocatehealth.org Hannah Tavalire Advocate Health Find this author on Google Scholar Find this author on PubMed Search for this author on this site Veronica Fitzpatrick Advocate Health Find this author on Google Scholar Find this author on PubMed Search for this author on this site Hannah Graham Advocate Health Find this author on Google Scholar Find this author on PubMed Search for this author on this site Shelly Verma Advocate Health Find this author on Google Scholar Find this author on PubMed Search for this author on this site Laura Krohn Advocate Health Find this author on Google Scholar Find this author on PubMed Search for this author on this site Katie Frank Advocate Health Find this author on Google Scholar Find this author on PubMed Search for this author on this site Daniel Vockeroth Advocate Health Find this author on Google Scholar Find this author on PubMed Search for this author on this site Brian Chicoine Advocate Health Find this author on Google Scholar Find this author on PubMed Search for this author on this site Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Importance Age based screening and prevention guidelines in healthcare are developed largely in populations without Down syndrome (DS). If disease risk among individuals with DS differs significantly relative to typically developing (TD) individuals of similar ages, standard guidelines may overlook critical windows of care. Objective To determine the age specific risk of ten common conditions in individuals with DS compared to a matched TD cohort to evaluate the presence of risk modification by age. Design Retrospective longitudinal cohort study. Setting Midwest healthcare system. Participants 4,912 individuals with DS and 37,924 TD controls, with clinical encounters between January 2005 and May 2025. Total person years (PYs) were 25,896 and 149,078 respectively. Exposure DS status Main Outcomes and Measures Incidence of acute sinusitis, anxiety, asthma, depression, gastroesophageal reflux disorder, nervous system disorders, respiratory failure, thyroid gland disorders, vasomotor/allergic rhinitis, and vitamin D deficiency. Incidence rate ratios (IRR) trajectories were analyzed using generalized additive mixed models. Wald tests assessed the presence of age modification. Results In our DS cohort (median age 24, 48% female), we found evidence of age-related risk modification in 6 of 10 conditions examined. The relative incidence of anxiety was significantly lower among individuals with DS in early childhood (at age 5, IRR 0.23, 95%CI 0.19, 0.29), compared to TD controls of the same age. However, risk in the DS cohort increased with age approaching equal levels with controls around ages 65. Similar trends were observed for depression. The association between DS and gastroesophageal disease was largely null except between ages 1 to 8, where the incidence among DS cohort was elevated (5 to 7 cases per 1000 PYs) compared to controls (2 to 3 cases per 1000 PYs). The association between DS and respiratory failure was statistically insignificant until age 53 to 70, where incidence among individuals with DS rose sharply (13 to 30 cases per 1000 PYs), while for TD counterparts it remained constant at 8-9 cases per 1000 PYs. Lastly, risk of vitamin D deficiency fluctuated with a peak at age 20 (IRR 2.34, 95%CI 2.02, 2.72). Conclusions and Relevance These findings demonstrate age effect modification among individuals with DS across a variety of disease conditions and highlight the importance of population-specific care guidelines. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Advocate Health Institutional Review Board approved the study protocol (IRB #00132715) and waived the informed consent requirement due to the retrospective nature of the study. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability All data produced in the present study are not available due to institutional restrictions of protected health information. Analytic code used to generate study findings are available upon request to authors. Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license . Back to top Previous Next Posted September 07, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Effects of Age on the Association between Down Syndrome and Common Disease Conditions Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Effects of Age on the Association between Down Syndrome and Common Disease Conditions Akaninyene Noah , Hannah Tavalire , Veronica Fitzpatrick , Hannah Graham , Shelly Verma , Laura Krohn , Katie Frank , Daniel Vockeroth , Brian Chicoine medRxiv 2026.09.02.26362053; doi: https://doi.org/10.64898/2026.09.02.26362053 Share This Article: Copy Citation Tools Effects of Age on the Association between Down Syndrome and Common Disease Conditions Akaninyene Noah , Hannah Tavalire , Veronica Fitzpatrick , Hannah Graham , Shelly Verma , Laura Krohn , Katie Frank , Daniel Vockeroth , Brian Chicoine medRxiv 2026.09.02.26362053; doi: https://doi.org/10.64898/2026.09.02.26362053 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Areas All Articles Addiction Medicine (616) Allergy and Immunology (897) Anesthesia (328) Cardiovascular Medicine (4781) Dentistry and Oral Medicine (476) Dermatology (411) Emergency Medicine (646) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1617) Epidemiology (15867) Forensic Medicine (32) Gastroenterology (1196) Genetic and Genomic Medicine (7006) Geriatric Medicine (728) Health Economics (1060) Health Informatics (5007) Health Policy (1429) Health Systems and Quality Improvement (1747) Hematology (583) HIV/AIDS (1338) Infectious Diseases (except HIV/AIDS) (16258) Intensive Care and Critical Care Medicine (1164) Medical Education (665) Medical Ethics (151) Nephrology (721) Neurology (7216) Nursing (366) Nutrition (1074) Obstetrics and Gynecology (1234) Occupational and Environmental Health (1002) Oncology (3584) Ophthalmology (1044) Orthopedics (395) Otolaryngology (449) Pain Medicine (466) Palliative Medicine (139) Pathology (704) Pediatrics (1784) Pharmacology and Therapeutics (733) Primary Care Research (759) Psychiatry and Clinical Psychology (5851) Public and Global Health (9719) Radiology and Imaging (2399) Rehabilitation Medicine and Physical Therapy (1438) Respiratory Medicine (1245) Rheumatology (636) Sexual and Reproductive Health (769) Sports Medicine (577) Surgery (772) Toxicology (107) Transplantation (303) Urology (288)
## Related Clinical Research

- [Carbon monoxide exposure may explain lower Parkinson's risk linked to smoking](https://medichelpline.com/clinical-feed/medical-news-today-0-why-smokers-may-have-a-lower-parkinson-s-risk-it-s-not-the-nicotine.md)
- [2026 Stroke Rehabilitation Guideline: Start Early and Address Physical, Cognitive, and Mental Heal](https://medichelpline.com/clinical-feed/medical-news-today-0-stroke-rehab-guidelines-emphasize-early-support-for-physical-cognitive-and.md)
- [PhenoAge DNA Methylation Acceleration Predicts Adolescent Depressive Symptoms: Longitudinal and MR](https://medichelpline.com/clinical-feed/medrxiv-13-dna-methylation-age-acceleration-depression-and-anxiety-evidence-from-a.md)
- [Understanding Parasitic Identification in Delusional Parasitosis](https://medichelpline.com/clinical-feed/plos-one-21-bridging-perception-and-reality-parasitic-identification-in-delusional.md)
- [Rising Demand for Plastic Surgery Among Young Men Fueled by Influencers and Looksmaxxing](https://medichelpline.com/clinical-feed/stat-news-1-opinion-more-young-men-are-coming-to-me-for-plastic-surgery-the-way-i-think.md)

## Navigation
- [← Back to Pediatrics Feed](https://medichelpline.com/clinical-feed/pediatrics.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.